关注
Gillet Jean-Pierre
Gillet Jean-Pierre
Faculty of Medicine, University of Namur
在 unamur.be 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mechanisms of multidrug resistance in cancer
JP Gillet, MM Gottesman
Multi-drug resistance in cancer, 47-76, 2010
8622010
The clinical relevance of cancer cell lines
JP Gillet, S Varma, MM Gottesman
Journal of the National Cancer Institute 105 (7), 452-458, 2013
7292013
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
JP Gillet, AM Calcagno, S Varma, M Marino, LJ Green, MI Vora, C Patel, ...
Proceedings of the National Academy of Sciences 108 (46), 18708-18713, 2011
5782011
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
JP Gillet, T Efferth, J Remacle
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1775 (2), 237-262, 2007
4682007
Toward a better understanding of the complexity of cancer drug resistance
MM Gottesman, O Lavi, MD Hall, JP Gillet
Annual review of pharmacology and toxicology 56 (1), 85-102, 2016
3332016
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics
AM Calcagno, CD Salcido, JP Gillet, CP Wu, JM Fostel, MD Mumau, ...
Journal of the National Cancer Institute 102 (21), 1637-1652, 2010
3332010
Drug resistance: still a daunting challenge to the successful treatment of AML
BC Shaffer, JP Gillet, C Patel, MR Baer, SE Bates, MM Gottesman
Drug Resistance Updates 15 (1-2), 62-69, 2012
3032012
Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes
JP Gillet, T Efferth, D Steinbach, J Hamels, F De Longueville, V Bertholet, ...
Cancer research 64 (24), 8987-8993, 2004
2792004
Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma
KG Chen, JC Valencia, JP Gillet, VJ Hearing, MM Gottesman
Pigment cell & melanoma research 22 (6), 740-749, 2009
2192009
ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia
D Steinbach, JP Gillet, A Sauerbrey, B Gruhn, K Dawczynski, V Bertholet, ...
Clinical cancer research 12 (14), 4357-4363, 2006
1722006
Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein
B Stordal, M Hamon, V McEneaney, S Roche, JP Gillet, JJ O’Leary, ...
PloS one 7 (7), e40717, 2012
1032012
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
AR Chakraborty, RW Robey, VL Luchenko, Z Zhan, RL Piekarz, JP Gillet, ...
Blood, The Journal of the American Society of Hematology 121 (20), 4115-4125, 2013
912013
Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer
JP Gillet, M M Gottesman
Current pharmaceutical biotechnology 12 (4), 686-692, 2011
892011
A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration
R Van De Ven, GL Scheffer, AW Reurs, JJ Lindenberg, R Oerlemans, ...
Blood, The Journal of the American Society of Hematology 112 (6), 2353-2359, 2008
822008
Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia
T Efferth, JP Gillet, A Sauerbrey, F Zintl, V Bertholet, F de Longueville, ...
Molecular cancer therapeutics 5 (8), 1986-1994, 2006
822006
Multidrug resistance–linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
JP Gillet, AM Calcagno, S Varma, B Davidson, M Bunkholt Elstrand, ...
Clinical Cancer Research 18 (11), 3197-3206, 2012
682012
LKB1/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes
L Homolya, D Fu, P Sengupta, M Jarnik, JP Gillet, L Vitale-Cross, ...
PloS one 9 (3), e91921, 2014
632014
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors
S Rottenberg, MA Vollebergh, B de Hoon, J de Ronde, PC Schouten, ...
Cancer research 72 (9), 2350-2361, 2012
602012
The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer
JP Gillet, B Macadangdang, RL Fathke, MM Gottesman, C Kimchi-Sarfaty
Gene Therapy of Cancer: Methods and Protocols, 5-54, 2009
602009
Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1
JP Gillet, MM Gottesman
Drug Resistance Updates 15 (1-2), 2-4, 2012
562012
系统目前无法执行此操作,请稍后再试。
文章 1–20